NHS AI strategy

Business news, market intelligence, and global industry analysis.

The Latest

Philadelphia jury orders Johnson & Johnson to pay $250,000 in talc powder lawsuit

Representative image showing the intersection of financial performance and cancer diagnostics, reflecting Exact Sciences’ record 2025 results and its pending acquisition by Abbott Laboratories.

Exact Sciences (NASDAQ: EXAS) earnings show why Abbott moved now on a $21bn diagnostics acquisition

Representative image. Global technology leaders collaborate on cross-border trust frameworks as the Trusted Tech Alliance launches to shape standards for AI, cloud infrastructure, and digital sovereignty.

Why the world’s biggest tech firms are racing to define trust before governments do

Bank of America boosts Brian Moynihan’s 2025 pay to $41m amid governance scrutiny

Representative image of an NHS radiologist using AI-assisted diagnostic tools for chest X-ray and eye scan analysis, part of the UK’s healthcare digital transformation in 2025.

How AI is powering faster triage and diagnostics across the NHS in 2025

NHS England is deploying AI in triage and diagnostics to cut wait times, improve accuracy, and modernise care. Learn how this strategy is unfolding in 2025.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

June 9, 2025